Skip to main content

RADIOACTIVE IODINE FOR THYROID MALIGNANCIES

Tracking # 20-1052902

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

IODINE-131 (I-131) IS A RADIOPHARMACEUTICAL THAT CAN BE USED FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES. THERAPEUTIC PURPOSE INCLUDES TREATMENT OF THYROID MALIGNANCY IN A POSTOPERATIVE PATIENT AND HYPERTHYROIDISM. THIS ARTICLE SUMMARIZES THYROID MALIGNANCIES, ANATOMY AND PHYSIOLOGY OF THE THYROID GLAND, INDICATIONS AND CONTRAINDICATIONS OF RADIOACTIVE IODINE TREATMENT FOR THYROID MALIGNANCY, PATIENT PREPARATION FOR TREATMENT, AND POSSIBLE TREATMENT COMPLICATIONS. WELL-DIFFERENTIATED THYROID CARCINOMAS RESPOND WELL TO I-131 THERAPY. THE ACTIVITY HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL HEALTHCARE TEAM IN PATIENT EVALUATION AND TREATMENT FOR BETTER CLINICAL OUTCOMES.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I